Cephalexin-Loaded Injectable Macroporous Calcium Phosphate Bone Cement

被引:33
作者
Hesaraki, Saeed [1 ]
Nemati, Roghayeh [1 ]
机构
[1] Mat & Energy Res Ctr, Dept Ceram, Tehran, Iran
关键词
calcium phosphate(s); drug release; bone graft; hydroxyapatite; DRUG-DELIVERY SYSTEM; BASIC PROPERTIES; HYDROXYAPATITE; RELEASE; OSTEOMYELITIS; BEHAVIOR; ANTIBIOTICS; GENTAMICIN; SULFATE;
D O I
10.1002/jbm.b.31222
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Different types of calcium phosphate cements (CPCs) have been studied as potential matrices for incorporating different types of antibiotics. All of these matrices were morphologically microporous whereas macroporosity is essential for rapid cement resorption and bone replacement. In this study, liberation of cephalexin monohydrate (CMH) from a macroporous CPC was investigated over 0.5-300 h in simulated body fluid and some mathematical models were fitted to the release profiles. Macroporosity was introduced into the cement matrix by using sodium dodecyl sulfate molecules as air-entraining agents and the effect of both surfactant and CMH on basic properties of the CPC was studied. Incorporation of CMH into the CPC composition increased the setting time, decreased the crystallinity of the formed apatite phase, and improved the injectability of the paste. The use of both CMH and sodium dodecyl sulfate did not affect the rate of conversion of the reactants into apatite phase while soaking the cements in simulated body fluid. Results showed that the liberation rate of the drug from porous CPC was higher than that of the nonporous CPC but same release patterns were experienced in both types of cements, that is, like to nonporous CPC, a time-dependent controlled release of the incorporated drug was obtained from macroporous CPC. The Weibull model was the best fitting-equation for release profiles of all cements. The liberated CMH was as active as fresh cephalexin. It is concluded that this macroporous CPC can be successfully used as drug carrier with controlled release profile for the treatment of bone infections. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 8913: 342-352, 2009
引用
收藏
页码:342 / 352
页数:11
相关论文
共 55 条
[1]   In vivo behavior of three different injectable hydraulic calcium phosphate cements [J].
Apelt, D ;
Theiss, F ;
El-Warrak, AO ;
Zlinszky, K ;
Bettschart-Wolfisberger, R ;
Bohner, M ;
Matter, S ;
Auer, JA ;
von Rechenberg, B .
BIOMATERIALS, 2004, 25 (7-8) :1439-1451
[2]   Quest for the Holy Grail to cure arthritis and osteoporosis: Emphasis on bone drug delivery systems [J].
Arkfeld, DG ;
Rubenstein, E .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (07) :939-944
[3]   Preparation of macroporous calcium phosphate cement tissue engineering scaffold [J].
Barralet, JE ;
Grover, L ;
Gaunt, T ;
Wright, AJ ;
Gibson, IR .
BIOMATERIALS, 2002, 23 (15) :3063-3072
[4]   TREATMENT OF OSTEOMYELITIS AND SEPTIC ARTHRITIS WITH CEFAMANDOLE [J].
BERNSTEIN, BM ;
FASS, RJ .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1982, 284 (03) :2-8
[5]   Technological issues for the development of more efficient calcium phosphate bone cements: A critical assessment [J].
Bohner, M ;
Gbureck, U ;
Barralet, JE .
BIOMATERIALS, 2005, 26 (33) :6423-6429
[6]   Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system [J].
Bohner, M ;
Lemaitre, J ;
VanLanduyt, P ;
Zambelli, PY ;
Merkle, HP ;
Gander, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (05) :565-572
[7]   Surgical treatment of a vertebral fracture associated with a haematogenous osteomyelitis in a dog [J].
Cabassu, J. ;
Moissonnier, P. .
VETERINARY AND COMPARATIVE ORTHOPAEDICS AND TRAUMATOLOGY, 2007, 20 (03) :227-230
[8]  
Clinical and Laboratory Standards Institute, 2006, M100S16 CLSI
[9]  
Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
[10]   Vancomycin release behaviour from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment [J].
Dion, A ;
Langman, M ;
Hall, G ;
Filiaggi, M .
BIOMATERIALS, 2005, 26 (35) :7276-7285